PREVENT痴呆研究中健康中年人群轻度创伤性脑损伤的神经影像与临床发现
该横断面分析使用PREVENT Dementia项目2014至2020年在英国和爱尔兰5个中心收集的基线数据,纳入40至59岁认知健康中年成人617例(中位年龄52岁,女性61.6%),其中223例(36.1%)有TBI史。TBI与更高的脑微出血计数相关(β=0.10;95%CI 0.01-0.18;P=.03),且随TBI次数增加呈剂量-反应关系(β=0.05;95%CI 0.01-0.09;P=.03);TBI与WMH等其他小血管病标志物无关。TBI还调节了微出血与血管危险因素及临床结局的关联,这些关联仅见于无TBI者;限制于仅报告轻度TBI者时结果仍成立。作者认为血管损伤对TBI相关神经退行性变的潜在贡献值得关注,并强调通过早期干预和预防减少TBI。
要点
- 健康中年成人617例中223例(36.1%)有TBI史,TBI与脑微出血计数升高相关(β=0.10;95%CI 0.01-0.18;P=.03)。
- TBI次数与微出血计数呈剂量-反应关系(β=0.05;95%CI 0.01-0.09;P=.03)。
- TBI与WMH等其他脑小血管病标志物无关联,提示TBI相关影像改变以微出血为主。
- TBI调节微出血与血管危险因素及临床结局的关联,关联仅见于无TBI者。
- 限制于仅报告轻度TBI者时上述结果仍成立,提示远期轻度TBI亦不可忽视。
适用人群与场景
- 英国和爱尔兰5个中心PREVENT Dementia项目2014至2020年基线数据中的认知健康中年成人,年龄40至59岁。
诊断标准与关键阈值
- TBI史采用脑损伤筛查问卷(Brain Injury Screening Questionnaire)评估。
研究设计与关键结果
- 横断面分析纳入617例参与者(中位[IQR]年龄52[47-56]岁;女性380例[61.6%]),223例(36.1%)有TBI史。
- TBI与更高的微出血计数相关(β=0.10;95%CI 0.01-0.18;P=.03),且随TBI事件数增加呈剂量-反应关系(β=0.05;95%CI 0.01-0.09;P=.03)。
- TBI与WMH等其他小血管病标志物无关联。
- TBI调节微出血与血管危险因素及临床结局的关联,关联仅见于无TBI者。
- 限制于仅报告轻度TBI者时,上述观察仍成立。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,血管损伤对TBI相关神经退行性变的潜在贡献为识别潜在靶点提供了有前景的方向。
- 作者认为,研究结果强调需要在临床照护和政策制定中通过早期干预和预防减少TBI。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Traumatic brain injuries (TBI) represent an important, potentially modifiable risk factor for dementia. Despite frequently observed vascular imaging changes in individuals with TBI, the relationships between TBI-associated changes in brain imaging and clinical outcomes have largely been overlooked in community cases of TBI.
OBJECTIVE: To assess whether TBI are associated with and interact with midlife changes in neuroimaging and clinical features in otherwise healthy individuals.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis used baseline data from the PREVENT Dementia program collected across 5 sites in the UK and Ireland between 2014 and 2020. Eligible participants were cognitively healthy midlife adults aged between 40 and 59 years. Data were analyzed between January 2023 and April 2024.
EXPOSURE: Lifetime TBI history was assessed using the Brain Injury Screening Questionnaire.
MAIN OUTCOMES AND MEASURES: Cerebral microbleeds and other markers of cerebral small vessel disease (white matter hyperintensities [WMH], lacunes, perivascular spaces) were assessed on 3T magnetic resonance imaging. Clinical measures were cognition, sleep, depression, gait, and cardiovascular disease (CVD) risk, assessed using Computerized Assessment of Information Processing (COGNITO), Pittsburgh Sleep Quality Index, Center for Epidemiologic Studies Depression Scale, clinical interviews, and the Framingham Risk Score, respectively.
RESULTS: Of 617 participants (median [IQR] age, 52 [47-56] years; 380 female [61.6%]), 223 (36.1%) had a history of TBI. TBI was associated with higher microbleed count (β = 0.10; 95% CI, 0.01-0.18; P = .03), with a dose-response association observed with increasing number of TBI events (β = 0.05; 95% CI, 0.01-0.09; P = .03). Conversely, TBI was not associated with other measures of small vessel disease, including WMH. Furthermore, TBI moderated microbleed associations with vascular risk factors and clinical outcomes, such that associations were present only in the absence of TBI. Importantly, observations held when analyses were restricted to individuals reporting only mild TBI.
CONCLUSIONS AND RELEVANCE: In this cross-sectional study of healthy middle-aged adults, detectable changes in brain imaging and clinical features were associated with remote, even mild, TBI in the general population. The potential contribution of vascular injury to TBI-related neurodegeneration presents promising avenues to identify potential targets, with findings highlighting the need to reduce TBI through early intervention and prevention in both clinical care and policymaking.
参考来源
- Low A, McKiernan E, Prats-Sedano MA, et al. Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study. JAMA Netw Open. 2024. PMID: 39145979. doi:10.1001/jamanetworkopen.2024.26774
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。